Company intelligence / Profile preview
Olatec Therapeutics LLC
New York City, New York, USAolatec.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Dapansutrile has demonstrated safety with no observed human toxicity in clinical trials. Positive Phase 2a proof-of-concept results were reported for acute gout flares showing reduction of inflammation mediated by IL‑1β. In heart failure patients, improvements in left ventricular ejection fraction and cardiopulmonary exercise time were observed without adverse cardiac effects. The compound is advancing into further Phase 2 studies including early Parkinson's disease supported by grants from Cure Parkinson's Foundation. Topical formulations have been tested successfully in osteoarthritis[1][4][6][7].
- Therapeutic areas
- PulmonologyCardiovascularRheumatologyEndocrinologyOncologyNeurology
- Modalities
- Small molecule oral therapeutics (NLRP3 inflammasome inhibitors)Oral selective NLRP3 antagonist compounds including dapansutrile and analogues
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Collaboration with Duke University among othersgrant support from Michael J. Fox Foundation for Parkinson’s Researchcollaboration with Cure Parkinson's Foundation[4][6]
Beyond the preview
Go deeper on Olatec Therapeutics LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Olatec Therapeutics LLC.